argenx SE (ARGX)
USD 558.55
(-5.34%)
USD 558.55
(-5.34%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.54 Billion USD | 44.93% |
| 2022 | 3.13 Billion USD | 9.96% |
| 2021 | 2.85 Billion USD | 24.75% |
| 2020 | 2.28 Billion EUR | 42.31% |
| 2019 | 1.6 Billion EUR | 142.65% |
| 2018 | 661.69 Million EUR | 48.7% |
| 2017 | 444.97 Million EUR | 300.02% |
| 2016 | 111.24 Million EUR | 121.37% |
| 2015 | 50.25 Million EUR | -29.37% |
| 2014 | 71.14 Million EUR | 105.99% |
| 2013 | 34.53 Million EUR | 50.63% |
| 2012 | 22.92 Million EUR | -28.21% |
| 2011 | 31.94 Million EUR | 160.5% |
| 2010 | 12.26 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.79 Billion USD | 0.0% |
| 2024 Q1 | - USD | -100.0% |
| 2023 Q2 | 3.19 Billion USD | 0.0% |
| 2023 FY | 4.54 Billion USD | 44.93% |
| 2023 Q4 | 4.54 Billion USD | 0.0% |
| 2023 Q3 | - USD | -100.0% |
| 2023 Q1 | - USD | -100.0% |
| 2022 Q2 | 3.24 Billion USD | 0.0% |
| 2022 FY | 3.13 Billion USD | 9.96% |
| 2022 Q4 | 3.13 Billion USD | 0.0% |
| 2022 Q3 | - USD | -100.0% |
| 2021 Q4 | 2.85 Billion USD | 0.0% |
| 2021 Q2 | 3.21 Billion USD | 0.0% |
| 2021 FY | 2.85 Billion USD | 24.75% |
| 2020 Q2 | 2.27 Billion EUR | 0.0% |
| 2020 FY | 2.28 Billion EUR | 42.31% |
| 2020 Q4 | 2.28 Billion EUR | 0.0% |
| 2019 Q4 | 1.43 Billion EUR | 0.0% |
| 2019 FY | 1.6 Billion EUR | 142.65% |
| 2019 Q2 | 1.14 Billion EUR | 0.0% |
| 2018 Q2 | 416.25 Million EUR | 0.0% |
| 2018 Q4 | 661.69 Million EUR | 0.0% |
| 2018 FY | 661.69 Million EUR | 48.7% |
| 2017 Q2 | 212.18 Million EUR | 0.0% |
| 2017 Q4 | 444.97 Million EUR | 0.0% |
| 2017 FY | 444.97 Million EUR | 300.02% |
| 2016 FY | 111.24 Million EUR | 121.37% |
| 2016 Q4 | 111.24 Million EUR | 0.0% |
| 2016 Q2 | 130.51 Million EUR | 0.0% |
| 2015 Q2 | 61.15 Million EUR | 0.0% |
| 2015 FY | 50.25 Million EUR | -29.37% |
| 2015 Q4 | 50.25 Million EUR | 0.0% |
| 2014 Q1 | 30.99 Million EUR | -10.26% |
| 2014 Q2 | 38 Million EUR | 22.61% |
| 2014 Q4 | 71.14 Million EUR | 0.0% |
| 2014 FY | 71.14 Million EUR | 105.99% |
| 2013 FY | 34.53 Million EUR | 50.63% |
| 2013 Q4 | 34.53 Million EUR | 0.0% |
| 2012 FY | 22.92 Million EUR | -28.21% |
| 2011 FY | 31.94 Million EUR | 160.5% |
| 2010 FY | 12.26 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | -205.253% |
| Alkermes plc | 2.13 Billion USD | -112.64% |
| Agenus Inc. | 313.91 Million USD | -1347.044% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -18.606% |
| Aptorum Group Limited | 20.64 Million USD | -21907.936% |
| Ardelyx, Inc. | 297.57 Million USD | -1426.471% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -493.357% |
| Bicycle Therapeutics plc | 595.34 Million USD | -662.997% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -6063.276% |
| ChromaDex Corporation | 54.96 Million USD | -8164.424% |
| Chimerix, Inc. | 212.77 Million USD | -2034.875% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -15966.762% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -930.111% |
| CRISPR Therapeutics AG | 2.22 Billion USD | -103.737% |
| Precision BioSciences, Inc. | 159.78 Million USD | -2742.928% |
| Dyadic International, Inc. | 8.21 Million USD | -55166.183% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -14211.462% |
| Fortress Biotech, Inc. | 167.52 Million USD | -2611.494% |
| Lantern Pharma Inc. | 43.64 Million USD | -10307.116% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -2715.509% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -31212.942% |
| Incyte Corporation | 6.78 Billion USD | 33.023% |
| IO Biotech, Inc. | 150.71 Million USD | -2913.879% |
| Jaguar Health, Inc. | 50.76 Million USD | -8848.364% |
| Novavax, Inc. | 1.85 Billion USD | -144.831% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -1094.105% |
| Opthea Limited | 188.79 Million USD | -2306.075% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -445.271% |
| ContextLogic Inc. | 423 Million USD | -973.867% |
| MiMedx Group, Inc. | 239.04 Million USD | -1800.236% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -2514.725% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -87766.939% |
| NextCure, Inc. | 129.41 Million USD | -3409.912% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -8320.067% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -12267.497% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -13962.902% |
| Vaxcyte, Inc. | 1.4 Billion USD | -222.637% |
| PDS Biotechnology Corporation | 59.39 Million USD | -7548.513% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -609.153% |
| Pharming Group N.V. | 462.85 Million USD | -881.402% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -11643.687% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -622.683% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -23904.101% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -23904.101% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -2647.676% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -9930.38% |
| Acelyrin, Inc. | 742.69 Million USD | -511.622% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -68865.948% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -70842.652% |
| Summit Therapeutics Inc. | 202.94 Million USD | -2138.226% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -6007.589% |
| Senti Biosciences, Inc. | 119.48 Million USD | -3701.729% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -1889.322% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -2601.047% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -54873.472% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -95054.561% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -868.145% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -3573.553% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -1552.109% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -860.675% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -44852.578% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -2017.637% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -401120.853% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -997.631% |
| Immix Biopharma, Inc. | 19.92 Million USD | -22697.599% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -1127.608% |
| MEI Pharma, Inc. | 41.37 Million USD | -10878.75% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -13917.336% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -1232.889% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -3774.991% |
| Fortress Biotech, Inc. | 167.52 Million USD | -2611.494% |
| Precigen, Inc. | 151.04 Million USD | -2907.394% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -13253.101% |
| AlloVir, Inc. | 190.79 Million USD | -2280.793% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -1106.653% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -797.334% |
| ImmuCell Corporation | 43.8 Million USD | -10268.991% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -599.576% |
| Onconetix, Inc. | 88.82 Million USD | -5014.145% |
| PureTech Health plc | 693.97 Million USD | -554.558% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -4550.108% |
| Elevation Oncology, Inc. | 89.09 Million USD | -4998.672% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -73141.825% |
| Seer, Inc. | 436.26 Million USD | -941.206% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -5466.942% |
| Innoviva, Inc. | 1.24 Billion USD | -265.294% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -3330.264% |
| ESSA Pharma Inc. | 149.12 Million USD | -2946.133% |
| GlycoMimetics, Inc. | 45.31 Million USD | -9923.856% |
| GT Biopharma, Inc. | 14.1 Million USD | -32095.464% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -1375.337% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -1779.355% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -862.575% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -8860.013% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -4670.888% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -719112.208% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -702.071% |
| Aptose Biosciences Inc. | 12.92 Million USD | -35051.422% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -20440.832% |
| Soligenix, Inc. | 9.79 Million USD | -46264.263% |
| Century Therapeutics, Inc. | 360.69 Million USD | -1159.377% |
| Kura Oncology, Inc. | 448.93 Million USD | -911.83% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -1569.107% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -26164.574% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -3995.576% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -2114.202% |
| Autolus Therapeutics plc | 375.38 Million USD | -1110.093% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -1705.17% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -1178.903% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -9145.416% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -587.071% |
| GRI Bio, Inc. | 2.95 Million USD | -153569.08% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -42732.26% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -2563.964% |
| IGM Biosciences, Inc. | 423.41 Million USD | -972.825% |
| INmune Bio, Inc. | 57 Million USD | -7869.085% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -1941.499% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -5311.473% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -17292.82% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -65893.452% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -5938.415% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -2984.694% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -2644.621% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -621.479% |
| Verastem, Inc. | 149.71 Million USD | -2934.009% |
| Abeona Therapeutics Inc. | 64 Million USD | -6997.369% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -786.932% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -2840.921% |
| Histogen Inc. | 19.07 Million USD | -23716.169% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -19954.848% |
| Surrozen, Inc. | 46.08 Million USD | -9757.765% |
| Organovo Holdings, Inc. | 6.34 Million USD | -71446.039% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -105327.213% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -3053.898% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -38388.883% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -5935.045% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -53219.928% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -1151.473% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -25004.224% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -957.857% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -35917.752% |
| Apollomics, Inc. | 55.38 Million USD | -8101.307% |
| Amarin Corporation plc | 831.68 Million USD | -446.176% |
| Mesoblast Limited | 669.15 Million USD | -578.837% |
| Turnstone Biologics Corp. | 112.81 Million USD | -3926.466% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -688.951% |
| Synaptogenix, Inc. | 31.11 Million USD | -14499.558% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -37182.157% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -728.822% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -77254.498% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -61742.882% |
| Exelixis, Inc. | 2.94 Billion USD | -54.382% |
| Better Therapeutics, Inc. | 22.94 Million USD | -19698.884% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -1146.083% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -475.921% |
| NLS Pharmaceutics AG | 1.84 Million USD | -245884.899% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -56832.778% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -30811.589% |
| Gritstone bio, Inc. | 177.76 Million USD | -2455.259% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -4662.485% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -25330.463% |
| Avid Bioservices, Inc. | 336.55 Million USD | -1249.685% |
| Insmed Incorporated | 1.32 Billion USD | -241.58% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -47077.973% |
| MediWound Ltd. | 66.45 Million USD | -6734.978% |
| OmniAb, Inc. | 401.98 Million USD | -1030.007% |
| Alector, Inc. | 621.82 Million USD | -630.502% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -1166.72% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -84363.704% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -7912.52% |
| Zai Lab Limited | 1.03 Billion USD | -338.336% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -849.403% |
| Aura Biosciences, Inc. | 255.07 Million USD | -1680.832% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -505.638% |
| Immunic, Inc. | 54.29 Million USD | -8265.638% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -1606.254% |
| Veracyte, Inc. | 1.13 Billion USD | -299.224% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -38321.228% |
| FibroGen, Inc. | 423.52 Million USD | -972.526% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -129204.241% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -95801.136% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -83562.886% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 60.131% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -51489.529% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -777.848% |
| TG Therapeutics, Inc. | 329.58 Million USD | -1278.227% |
| Galecto, Inc. | 38.22 Million USD | -11782.852% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -15740.626% |
| Fortrea Holdings Inc. | 4.35 Billion USD | -4.252% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -1829.644% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -18185.396% |
| XBiotech Inc. | 227.24 Million USD | -1898.943% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -4662.485% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -3085.454% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -1488.739% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -3452.431% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -1089.128% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -204.656% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -1145.048% |
| Vaxxinity, Inc. | 44.35 Million USD | -10141.603% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -778.687% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -24309.572% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -1389.086% |
| NexImmune, Inc. | 8.59 Million USD | -52756.469% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -42292.697% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -26421.599% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 86.268% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -20406.664% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -1157907.469% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -2520.714% |
| Ainos, Inc. | 31.84 Million USD | -14165.706% |
| Pluri Inc. | 39.52 Million USD | -11392.038% |
| Prothena Corporation plc | 696.38 Million USD | -552.294% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -1507.29% |
| Celularity Inc. | 143.88 Million USD | -3056.918% |
| Rallybio Corporation | 115.62 Million USD | -3828.782% |
| Cue Biopharma, Inc. | 61.53 Million USD | -7282.509% |
| MeiraGTx Holdings plc | 458.16 Million USD | -891.439% |
| Omeros Corporation | 378.26 Million USD | -1100.854% |
| Humacyte, Inc. | 128.22 Million USD | -3442.623% |
| Immunocore Holdings plc | 597 Million USD | -660.879% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -14431.68% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -6528.423% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -332.924% |
| CalciMedica, Inc. | 12.18 Million USD | -37179.097% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -1690.837% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -2557.838% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -1360.433% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -703.55% |
| Pulmatrix, Inc. | 33.95 Million USD | -13276.695% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -16633.434% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -3124.849% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -249.157% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -3389.125% |
| Cytokinetics, Incorporated | 824.31 Million USD | -451.058% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -21404.796% |
| Nutriband Inc. | 7.51 Million USD | -60327.896% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -5653.297% |
| Vor Biopharma Inc. | 209.82 Million USD | -2064.848% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 37.107% |
| Evogene Ltd. | 51.1 Million USD | -8789.176% |
| ProKidney Corp. | 420.55 Million USD | -980.118% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -8184.168% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -47613.502% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -731.373% |
| CorMedix Inc. | 82.05 Million USD | -5435.535% |
| BioLineRx Ltd. | 63.92 Million USD | -7005.918% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -1028.373% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -16008.007% |
| Atai Life Sciences N.V. | 293.47 Million USD | -1447.802% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -2684.573% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -3465.005% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -708.228% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -4596.552% |
| MediciNova, Inc. | 66.26 Million USD | -6754.473% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -5064.936% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -101694.855% |
| GeoVax Labs, Inc. | 9.28 Million USD | -48831.928% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -672.217% |
| Biomea Fusion, Inc. | 199.92 Million USD | -2172.058% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -138.677% |
| Mereo BioPharma Group plc | 66.49 Million USD | -6730.867% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -836.404% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -641.166% |
| Absci Corporation | 234.48 Million USD | -1837.248% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -61997.854% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -1236.446% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -2651.637% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -763.057% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -1535.784% |
| Allakos Inc. | 243.61 Million USD | -1764.643% |
| Imunon, Inc. | 21.91 Million USD | -20624.718% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -1662.733% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -630.866% |
| BioAtla, Inc. | 119.65 Million USD | -3696.201% |
| NLS Pharmaceutics AG | 1.84 Million USD | -245884.899% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -140970.124% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -606.627% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -4634.933% |
| XOMA Corporation | 234.3 Million USD | -1838.728% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -1953.228% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -3509.594% |
| aTyr Pharma, Inc. | 122.06 Million USD | -3621.283% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -2851.507% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -682.817% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -826.231% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -4011.975% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -29868.269% |
| Akari Therapeutics, Plc | 4.35 Million USD | -104204.432% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -26561.79% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -162.074% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -147191.784% |
| UroGen Pharma Ltd. | 178.31 Million USD | -2447.492% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -864.969% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -817307.844% |
| Orgenesis Inc. | 14.55 Million USD | -31115.352% |
| Entera Bio Ltd. | 11.76 Million USD | -38509.928% |
| GH Research PLC | 226.3 Million USD | -1907.273% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -8205.222% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -4128.059% |
| Xencor, Inc. | 952.69 Million USD | -376.802% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -58258.063% |
| Replimune Group, Inc. | 487.72 Million USD | -831.362% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -56180.608% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -600.521% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -147191.784% |
| Portage Biotech Inc. | 7.77 Million USD | -58293.855% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -101694.855% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -1540.202% |
| OncoCyte Corporation | 74.89 Million USD | -5965.345% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -223308.95% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -78399.019% |
| Purple Biotech Ltd. | 44.3 Million USD | -10153.393% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -13210.842% |
| scPharmaceuticals Inc. | 94.47 Million USD | -4707.902% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -25073.004% |
| HilleVax, Inc. | 344.43 Million USD | -1218.818% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -142924.496% |
| Tharimmune, Inc. | 10.94 Million USD | -41397.304% |
| Genprex, Inc. | 10.67 Million USD | -42469.878% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -815.458% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -4619.339% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -187140.643% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -108951.07% |
| OKYO Pharma Limited | 1.54 Million USD | -294622.903% |
| Savara Inc. | 177.56 Million USD | -2458.209% |
| Curis, Inc. | 77.28 Million USD | -5777.77% |
| Daré Bioscience, Inc. | 21.28 Million USD | -21243.916% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -7003.273% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -56076.824% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -23349.786% |
| BeiGene, Ltd. | 5.8 Billion USD | 21.753% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -37228.112% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -117.489% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -1169.017% |
| Erasca, Inc. | 395.29 Million USD | -1049.125% |
| bluebird bio, Inc. | 619.16 Million USD | -633.647% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -104967.553% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 33.605% |
| DBV Technologies S.A. | 182.98 Million USD | -2382.407% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -104967.553% |
| Moderna, Inc. | 18.42 Billion USD | 75.348% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -24835.269% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -39106.439% |
| Molecular Templates, Inc. | 35.38 Million USD | -12737.967% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -3185.327% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -475.787% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -1395.435% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -4270.017% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -875.557% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -1349.241% |
| MacroGenics, Inc. | 306.82 Million USD | -1380.496% |
| RenovoRx, Inc. | 1.46 Million USD | -309753.888% |
| Adicet Bio, Inc. | 207.29 Million USD | -2091.301% |
| Prime Medicine, Inc. | 193.85 Million USD | -2243.273% |
| Aditxt, Inc. | 44.57 Million USD | -10089.835% |
| Adagene Inc. | 115.72 Million USD | -3825.087% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -101881.708% |
| Quantum-Si incorporated | 298.25 Million USD | -1423.037% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -205.386% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -58823.149% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -1193.112% |
| SciSparc Ltd. | 11.18 Million USD | -40522.948% |
| Vericel Corporation | 353.65 Million USD | -1184.425% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -37094.821% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -7883.144% |
| Generation Bio Co. | 374.75 Million USD | -1112.104% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -1683.692% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -2764.693% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -1230.675% |
| Invivyd, Inc. | 229.18 Million USD | -1882.04% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -438.219% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -37227.189% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -2390.519% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -22140.785% |
| 2seventy bio, Inc. | 565.42 Million USD | -703.369% |
| ADMA Biologics, Inc. | 329.18 Million USD | -1279.923% |
| Clene Inc. | 52.34 Million USD | -8578.585% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -7633.907% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -3397.05% |
| GeoVax Labs, Inc. | 9.28 Million USD | -48831.928% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -594.885% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -4284.14% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -3383.854% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -4556.446% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -6298.099% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -1772.769% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -131.747% |
| Evaxion Biotech A/S | 12.88 Million USD | -35143.947% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -1702.134% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -503.498% |
| Trevena, Inc. | 40.6 Million USD | -11086.942% |
| Surrozen, Inc. | 46.08 Million USD | -9757.765% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -1911.21% |
| Cingulate Inc. | 3.49 Million USD | -130002.857% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -27216.483% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -6814.992% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -38775.507% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -1591.684% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -506.505% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -3508.218% |
| Clearmind Medicine Inc. | 4.32 Million USD | -104942.77% |
| Kronos Bio, Inc. | 213.27 Million USD | -2029.82% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -2742.874% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -52962.317% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -1132.722% |
| Statera Biopharma, Inc. | 21.16 Million USD | -21357.372% |
| ImmunityBio, Inc. | 504.45 Million USD | -800.474% |
| Korro Bio, Inc. | 221.66 Million USD | -1949.263% |
| Kineta, Inc. | 10.28 Million USD | -44083.037% |
| BioVie Inc. | 25.2 Million USD | -17919.66% |
| Codexis, Inc. | 136.56 Million USD | -3226.322% |
| Celularity Inc. | 143.88 Million USD | -3056.918% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -614.95% |
| Celcuity Inc. | 191.21 Million USD | -2275.522% |
| Virax Biolabs Group Limited | 5.48 Million USD | -82731.577% |
| Cibus, Inc. | 544.41 Million USD | -734.38% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -3508.161% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -22010.874% |
| IN8bio, Inc. | 33.7 Million USD | -13375.505% |
| Kodiak Sciences Inc. | 479.37 Million USD | -847.585% |
| Annexon, Inc. | 297.67 Million USD | -1425.984% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -2525.547% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -3204.351% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -21537.965% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -51.918% |
| Eyenovia, Inc. | 28.77 Million USD | -15683.728% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -1870.458% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -62780.094% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -7355.697% |
| Arcellx, Inc. | 825.13 Million USD | -450.513% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -5464.215% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -882.631% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -14672.221% |
| Moolec Science SA | 24.05 Million USD | -18786.547% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -1364.718% |
| Geron Corporation | 394.07 Million USD | -1052.686% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -4366.088% |
| Royalty Pharma plc | 16.38 Billion USD | 72.271% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -663.479% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -64840.359% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -37667.844% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -1909.404% |
| Humacyte, Inc. | 128.22 Million USD | -3442.623% |
| Structure Therapeutics Inc. | 482.01 Million USD | -842.385% |
| 89bio, Inc. | 596.26 Million USD | -661.814% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -1701.476% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -245438.27% |
| Genelux Corporation | 27.89 Million USD | -16185.297% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -4980.879% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -1879.897% |
| Notable Labs, Ltd. | 19.54 Million USD | -23145.781% |
| Liquidia Corporation | 120.43 Million USD | -3671.834% |
| Mustang Bio, Inc. | 17.74 Million USD | -25502.852% |
| Immunovant, Inc. | 666.71 Million USD | -581.322% |
| Quantum-Si incorporated | 298.25 Million USD | -1423.037% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -3045.725% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -8287.109% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -2487.617% |
| Acasti Pharma Inc. | 73.3 Million USD | -6097.078% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -99684.218% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -17292.82% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -370.82% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -87424.658% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -19839.678% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -8702.701% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -2413.937% |
| PepGen Inc. | 143.05 Million USD | -3075.389% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -11785.962% |
| United Therapeutics Corporation | 7.16 Billion USD | 36.62% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -23577.133% |
| Solid Biosciences Inc. | 164.93 Million USD | -2654.023% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -77254.498% |
| Immuneering Corporation | 102.58 Million USD | -4328.014% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -105327.213% |
| Silo Pharma, Inc. | 7.74 Million USD | -58541.561% |
| Belite Bio, Inc | 94.64 Million USD | -4699.622% |
| XOMA Corporation | 234.3 Million USD | -1838.728% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -1847.981% |
| Bionomics Limited | 27.64 Million USD | -16328.958% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -1031.642% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -4129.949% |
| uniQure N.V. | 831.68 Million USD | -446.173% |
| Cassava Sciences, Inc. | 151.66 Million USD | -2895.1% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -101881.708% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -1558.527% |
| Forte Biosciences, Inc. | 38.98 Million USD | -11553.304% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -111422.977% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -12233.246% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -62780.094% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -129204.241% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -38327.02% |
| Altimmune, Inc. | 210.64 Million USD | -2056.503% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -483.954% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -4129.949% |
| Compugen Ltd. | 121.33 Million USD | -3643.763% |
| Peak Bio, Inc. | 2.59 Million USD | -174851.154% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -2535.953% |
| Benitec Biopharma Inc. | 52.21 Million USD | -8600.36% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -1228.752% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -12963.175% |
| Zura Bio Limited | 100.84 Million USD | -4404.485% |
| PolyPid Ltd. | 15.37 Million USD | -29450.208% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -3708.04% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -12963.175% |
| Instil Bio, Inc. | 325.63 Million USD | -1294.975% |
| Immunome, Inc. | 148.54 Million USD | -2958.071% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -2795.591% |
| Verona Pharma plc | 308.12 Million USD | -1374.231% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -5123.678% |
| Shattuck Labs, Inc. | 159.56 Million USD | -2746.794% |
| CervoMed Inc. | 9.97 Million USD | -45449.746% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -2310.355% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -39788.11% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -2431.957% |
| Moolec Science SA | 24.05 Million USD | -18786.547% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -74153.745% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -2526.542% |
| AnaptysBio, Inc. | 452.38 Million USD | -904.104% |
| Design Therapeutics, Inc. | 289.64 Million USD | -1468.295% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -6137.498% |
| NeurAxis, Inc. | 509.49 Thousand USD | -891455.61% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -83740.126% |
| Lumos Pharma, Inc. | 40.63 Million USD | -11077.858% |
| Achilles Therapeutics plc | 161.45 Million USD | -2713.434% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -5123.678% |
| 180 Life Sciences Corp. | 5.25 Million USD | -86267.121% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -6349.808% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -52962.317% |
| Nutriband Inc. | 7.51 Million USD | -60327.896% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -1683.552% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -2179.195% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -5860.292% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -7743.183% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -762.699% |
| Palisade Bio, Inc. | 14.05 Million USD | -32226.06% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -2060.041% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -211.188% |
| Neurogene Inc. | 222.57 Million USD | -1940.885% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -602.492% |
| AEON Biopharma, Inc. | 6.84 Million USD | -66261.695% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -902.67% |
| Sesen Bio, Inc. | 189.17 Million USD | -2301.206% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -1570.838% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -33027.925% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -482.104% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -1601.333% |
| Athira Pharma, Inc. | 160.24 Million USD | -2734.696% |
| Vaccinex, Inc. | 3.63 Million USD | -125002.121% |
| HCW Biologics Inc. | 28.51 Million USD | -15830.814% |
| XOMA Corporation | 234.3 Million USD | -1838.728% |
| Nektar Therapeutics | 398.03 Million USD | -1041.226% |
| Arvinas, Inc. | 1.3 Billion USD | -248.188% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -26561.79% |
| Merus N.V. | 458.49 Million USD | -890.734% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -2122.707% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -2420.731% |
| Rezolute, Inc. | 132.73 Million USD | -3322.149% |
| Clene Inc. | 52.34 Million USD | -8578.585% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -30337.518% |
| BeyondSpring Inc. | 24.8 Million USD | -18210.456% |
| Synlogic, Inc. | 75.55 Million USD | -5912.519% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -38194.2% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -48409.804% |
| Peak Bio, Inc. | 2.59 Million USD | -174851.154% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -2498.17% |
| Krystal Biotech, Inc. | 818.35 Million USD | -455.072% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -1789.243% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -525.866% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -126884.541% |
| MannKind Corporation | 475.19 Million USD | -855.908% |
| Ikena Oncology, Inc. | 192.09 Million USD | -2264.73% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -33864.842% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -3797.801% |
| Gossamer Bio, Inc. | 311.91 Million USD | -1356.308% |
| CohBar, Inc. | 16.36 Million USD | -27656.021% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -12818.289% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -61997.854% |
| Legend Biotech Corporation | 1.84 Billion USD | -145.723% |
| Mural Oncology plc | 301.74 Million USD | -1405.396% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -14452.164% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -79867.15% |
| Disc Medicine, Inc. | 367.99 Million USD | -1134.377% |
| Champions Oncology, Inc. | 26.13 Million USD | -17282.741% |
| REGENXBIO Inc. | 573.97 Million USD | -691.41% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -167636.906% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -2842.273% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -37516.893% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -1235.88% |
| Vaxart, Inc. | 91.83 Million USD | -4846.595% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -7482.911% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -2962.464% |
| Cellectis S.A. | 334.27 Million USD | -1258.919% |
| Longeveron Inc. | 12.17 Million USD | -37200.526% |
| Repare Therapeutics Inc. | 253.9 Million USD | -1689.067% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -39.144% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -2161.651% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -117.489% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -279435.877% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -1535.678% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -2685.11% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -3173.985% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -17698.205% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 80.016% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -293.656% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -37094.821% |
| Veru Inc. | 50.59 Million USD | -8877.913% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -9871.809% |
| Cingulate Inc. | 3.49 Million USD | -130002.857% |
| Passage Bio, Inc. | 150.54 Million USD | -2917.342% |
| Context Therapeutics Inc. | 16.06 Million USD | -28179.48% |
| Exicure, Inc. | 11.58 Million USD | -39126.753% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -1107.946% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -2710.197% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -25898.5% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -1265.147% |
| Nuvalent, Inc. | 732.38 Million USD | -520.229% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -30296.373% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -4972.312% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -31909.429% |
| OmniAb, Inc. | 401.98 Million USD | -1030.007% |
| Anew Medical, Inc. | 19.45 Million USD | -23247.394% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -16896.048% |
| Lipocine Inc. | 23 Million USD | -19648.897% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -3149.092% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -1386.577% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -5311.473% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -3637.418% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -57145.848% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -414.856% |
| Ocugen, Inc. | 64.54 Million USD | -6937.442% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -3547.36% |
| Q32 Bio Inc. | 306.11 Million USD | -1383.886% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -107848.146% |
| Alumis Inc. Common Stock | 89.61 Million USD | -4969.029% |
| Equillium, Inc. | 50.53 Million USD | -8889.626% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -5940.904% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -10905.743% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -266969.406% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -17276.757% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -6949.018% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -121776.047% |
| Dominari Holdings Inc. | 57.55 Million USD | -7791.966% |
| Edesa Biotech, Inc. | 8.89 Million USD | -50993.754% |
| vTv Therapeutics Inc. | 11.01 Million USD | -41127.609% |
| Bio-Techne Corporation | 2.81 Billion USD | -61.47% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -384.726% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -459.797% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -1535.949% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -10792.662% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -580.428% |
| Nkarta, Inc. | 378.88 Million USD | -1098.902% |
| BioCardia, Inc. | 2.98 Million USD | -151974.255% |
| Iterum Therapeutics plc | 26.25 Million USD | -17198.671% |